We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

131 hedge funds and large institutions have $528M invested in Voyager Therapeutics in 2019 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 27 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,200% more call options, than puts

Call options by funds: $1.67M | Put options by funds: $18K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

89% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 27

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

5% more funds holding

Funds holding: 125 → 131 (+6)

3.54% more ownership

Funds ownership: 79.52% → 83.06% (+3.5%)

34% less capital invested

Capital invested by funds: $796M → $528M (-$268M)

Holders
131
Holders Change
+6
Holders Change %
+4.8%
% of All Funds
2.87%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
28
Increased
51
Reduced
27
Closed
22
Calls
$1.67M
Puts
$18K
Net Calls
+$1.66M
Net Calls Change
-$4.71M

Top Buyers

Rank Fund Capital Flow
1
ClearBridge Investments
ClearBridge Investments
New York
+$18.1M
2
BC
Boxer Capital
California
+$8.4M
3
Renaissance Technologies
Renaissance Technologies
New York
+$7.2M
4
FCMI
Foresite Capital Management IV
California
+$6.17M
5
N
Nuveen
North Carolina
+$5.55M

Top Sellers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
-$20.4M
2
PHS
PFM Health Sciences
California
-$18.6M
3
Millennium Management
Millennium Management
New York
-$13.3M
4
HCM
Highline Capital Management
New York
-$8.08M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
Rockefeller Capital Management
101
Rockefeller Capital Management
New York
$103K -$2.9K -138 -2%
Macquarie Group
102
Macquarie Group
Australia
$98K – – –
CIP
103
Convergence Investment Partners
Florida
$92K +$29.1K +1,387 +35%
Royal Bank of Canada
104
Royal Bank of Canada
Ontario, Canada
$86K +$14.4K +685 +16%
Legal & General Group
105
Legal & General Group
United Kingdom
$81K – – –
Victory Capital Management
106
Victory Capital Management
Texas
$73K +$89.1K +4,245 New
QT
107
Quantbot Technologies
New York
$73K +$90.2K +4,295 New
BNP Paribas Financial Markets
108
BNP Paribas Financial Markets
France
$60.9K +$24K +1,143 +48%
Bank of Montreal
109
Bank of Montreal
Ontario, Canada
$56K +$8.96K +427 +15%
HPC
110
HM Payson & Co
Maine
$40K – – –
Zurich Cantonal Bank
111
Zurich Cantonal Bank
Switzerland
$37K – – –
LWCFA
112
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$36K – – –
AIP
113
Ameritas Investment Partners
Nebraska
$35K +$6.3K +300 +17%
QT
114
Quantamental Technologies
New York
$25K +$30K +1,430 New
RA
115
Royce & Associates
New York
$24K +$29.8K +1,420 New
FWM
116
Focused Wealth Management
New York
$17K – – –
SPIA
117
Steward Partners Investment Advisory
New York
$17K – – –
Lazard Asset Management
118
Lazard Asset Management
New York
$15K +$19.2K +913 New
Fifth Third Bancorp
119
Fifth Third Bancorp
Ohio
$14K +$16.8K +800 New
AIM
120
Advantage Investment Management
Iowa
$10K – – –
TRCT
121
Tower Research Capital (TRC)
New York
$9K +$11.3K +539 New
WEC
122
Winslow Evans & Crocker
Massachusetts
$6K +$6K +286 New
CG
123
Cutler Group
California
$6K +$8.4K +400 New
Daiwa Securities Group
124
Daiwa Securities Group
Japan
$4K – – –
IA
125
IFP Advisors
Florida
$3K +$3.15K +150 New
3 4
5
6 7

VYGR Hedge Fund Activity: Q3 2019 in Review

131 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q3 2019, worth a combined $528M — down 34% from $796M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new VYGR positions and 22 closed out — a net gain of 6 holders — while 51 added to existing stakes and 27 trimmed.

The largest buyer was ClearBridge Investments, adding an estimated $18.1M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $20.4M sold.

  • 131 institutional investors held Voyager Therapeutics (VYGR) as of Q3 2019, up from 125 in Q2 2019.
  • Funds reported $528M of Voyager Therapeutics stock for Q3 2019, down 34% quarter-over-quarter.
  • 28 funds opened new Voyager Therapeutics positions in Q3 2019 and 22 closed out, a net change of +6 holders.
  • The largest Voyager Therapeutics buyer in Q3 2019 was ClearBridge Investments, an estimated $18.1M added.
  • The largest Voyager Therapeutics seller in Q3 2019 was Farallon Capital Management, an estimated $20.4M sold.

Based on aggregated 13F filings for Q3 2019.